Akshara Richhariya

604 total citations
24 papers, 421 citations indexed

About

Akshara Richhariya is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Akshara Richhariya has authored 24 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Genetics and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Akshara Richhariya's work include Chronic Lymphocytic Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (7 papers) and Bone health and treatments (4 papers). Akshara Richhariya is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (7 papers) and Bone health and treatments (4 papers). Akshara Richhariya collaborates with scholars based in United States, United Kingdom and Poland. Akshara Richhariya's co-authors include Shravanthi R. Gandra, Karen Chung, Peter P. Tóth, Andrew G. Glass, Arun Balakumaran, John Edelsberg, Lois Lamerato, Gerry Oster, Kathryn Richert-Boe and Greg G. Wolff and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Akshara Richhariya

23 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Akshara Richhariya United States	12	199	167	84	70	64	24	421
Dirk Elling Germany	16	303 1.5×	194 1.2×	115 1.4×	65 0.9×	40 0.6×	51	656
Christophe Desauw France	8	305 1.5×	141 0.8×	209 2.5×	50 0.7×	35 0.5×	27	603
Caroline Brammer United Kingdom	8	220 1.1×	142 0.9×	109 1.3×	208 3.0×	40 0.6×	14	546
Mandar Nadkarni India	13	216 1.1×	164 1.0×	91 1.1×	67 1.0×	27 0.4×	22	441
Stephen S. Grubbs United States	10	354 1.8×	78 0.5×	110 1.3×	40 0.6×	108 1.7×	30	538
Burkhard Otremba Germany	11	234 1.2×	47 0.3×	133 1.6×	60 0.9×	36 0.6×	41	590
Todd A. Pezzi United States	15	280 1.4×	114 0.7×	271 3.2×	52 0.7×	67 1.0×	37	566
Jorge Otero Colombia	12	307 1.5×	127 0.8×	319 3.8×	78 1.1×	27 0.4×	41	659
Thomas M. Churilla United States	13	193 1.0×	191 1.1×	191 2.3×	53 0.8×	44 0.7×	33	548
Diana Almader‐Douglas United States	11	175 0.9×	65 0.4×	88 1.0×	70 1.0×	52 0.8×	30	442

Countries citing papers authored by Akshara Richhariya

Since Specialization

Citations

This map shows the geographic impact of Akshara Richhariya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akshara Richhariya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akshara Richhariya more than expected).

Fields of papers citing papers by Akshara Richhariya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akshara Richhariya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akshara Richhariya. The network helps show where Akshara Richhariya may publish in the future.

Co-authorship network of co-authors of Akshara Richhariya

This figure shows the co-authorship network connecting the top 25 collaborators of Akshara Richhariya. A scholar is included among the top collaborators of Akshara Richhariya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akshara Richhariya. Akshara Richhariya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bonafede, Machaon, Joseph Feliciano, Qian Cai, et al.. (2018). Real-world analysis of cost, health care resource utilization, and supportive care in Hodgkin lymphoma patients with frontline failure. ClinicoEconomics and Outcomes Research. Volume 10. 629–641. 12 indexed citations

Troy, Jesse D., Susan C. Locke, Greg Samsa, et al.. (2018). Patient-reported distress in Hodgkin lymphoma across the survivorship continuum. Supportive Care in Cancer. 27(7). 2453–2462. 20 indexed citations

Straus, David J., Machaon Bonafede, Joseph Feliciano, et al.. (2017). Real World Clinical and Economic Burden of Patients with Hodgkin Lymphoma (HL) Who Fail Frontline (FL) Therapy in the US. Blood. 130. 2128–2128. 1 indexed citations

Perales, Miguel‐Angel, Machaon Bonafede, Qian Cai, et al.. (2017). Real-World Economic Burden Associated with Transplantation-Related Complications. Biology of Blood and Marrow Transplantation. 23(10). 1788–1794. 10 indexed citations

Punekar, Rajeshwari, Kathleen M. Fox, Carly J. Paoli, et al.. (2017). Lipid-lowering treatment modifications among patients with hyperlipidemia and a prior cardiovascular event: a US retrospective cohort study. Current Medical Research and Opinion. 33(5). 869–876. 4 indexed citations

Gautam, Ashish, Yanyan Zhu, Esprit Ma, et al.. (2017). Brentuximab vedotin consolidation post-autologous stem cell transplant in Hodgkin lymphoma patients at risk of residual disease: number needed to treat. Leukemia & lymphoma. 59(1). 69–76. 2 indexed citations

Bonafede, Machaon, Akshara Richhariya, Qian Cai, et al.. (2017). Real-world economic burden of hematopoietic cell transplantation among a large US commercially insured population with hematologic malignancies. Journal of Medical Economics. 20(12). 1244–1251. 16 indexed citations

Fox, Kathleen M., Neil C. Josephson, & Akshara Richhariya. (2016). Toxicity Burden of Bleomycin Treatment in Hodgkin Lymphoma: A Systematic Literature Review. Blood. 128(22). 3566–3566. 7 indexed citations

Wang, Anthony, Akshara Richhariya, Shravanthi R. Gandra, et al.. (2016). Systematic Review of Low‐Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia. Journal of the American Heart Association. 5(7). 73 indexed citations

10.

Josephson, Neil C., Phillip M. Garfin, Akshara Richhariya, et al.. (2016). Real-World Clinical and Economic Burden of Hematopoietic Cell Transplantation Among a Large US Commercially Insured Populationhematopoietic CELL Transplantation Among a Large US Commercially Insured Population. Blood. 128(22). 2368–2368. 1 indexed citations

11.

Ramsey, Scott D., Auayporn Nademanee, Tamás Masszi, et al.. (2016). Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma. British Journal of Haematology. 175(5). 860–867. 21 indexed citations

12.

Parker, Christopher, Gemma L. Kay, Esprit Ma, et al.. (2016). Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant: A cost-effectiveness analysis updated with 5-year follow-up data from the pivotal trial.. Journal of Clinical Oncology. 34(7_suppl). 19–19. 1 indexed citations

13.

Bonafede, Machaon, Barbara H. Johnson, Shravanthi R. Gandra, & Akshara Richhariya. (2015). Medical costs associated with cardiovascular events among high-risk patients with hyperlipidemia. ClinicoEconomics and Outcomes Research. 7. 337–337. 21 indexed citations

14.

Punekar, Rajeshwari, Kathleen M. Fox, Akshara Richhariya, et al.. (2015). Burden of First and Recurrent Cardiovascular Events Among Patients With Hyperlipidemia. Clinical Cardiology. 38(8). 483–491. 31 indexed citations

15.

Richhariya, Akshara, Kathleen M. Fox, Rajeshwari Punekar, et al.. (2015). Abstract 307: Gender Differences in Recurrent Cardiovascular Events Among High-risk Patients With Hyperlipidemia. Circulation Cardiovascular Quality and Outcomes. 8(suppl_2). 2 indexed citations

16.

Oster, Gerry, Lois Lamerato, Andrew G. Glass, et al.. (2014). Use of intravenous bisphosphonates in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems. Supportive Care in Cancer. 22(5). 1363–1373. 25 indexed citations

17.

Oster, Gerry, Lois Lamerato, Andrew G. Glass, et al.. (2013). Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems. Supportive Care in Cancer. 21(12). 3279–3286. 120 indexed citations

18.

Richhariya, Akshara. (2012). Time associated with intravenous zoledronic acid administration in patients with breast or prostate cancer and bone metastasis. Cancer Management and Research. 4. 55–55. 11 indexed citations

19.

Freedland, Stephen J., Akshara Richhariya, Huei Wang, Karen Chung, & Neal D. Shore. (2012). Treatment Patterns in Patients With Prostate Cancer and Bone Metastasis Among US Community-based Urology Group Practices. Urology. 80(2). 293–298. 18 indexed citations

20.

Richhariya, Akshara, et al.. (2011). PCN26 BUDGET IMPACT MODEL OF DENOSUMAB FOR SKELETAL RELATED EVENT (SRE) PREVENTION IN PATIENTS WITH BREAST AND PROSTATE CANCER. Value in Health. 14(3). A159–A159. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact